Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marco Pravetoni
Vaccines to Treat Opioid Use Disorders and to Reduce Opioid Overdoses
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Alum Adjuvant Is More Effective Than MF59 at Prompting Early Germinal Center Formation in Response to Peptide-Protein Conjugates and Enhancing Efficacy of a Vaccine Against Opioid Use Disorders
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Related publications
Examining Fatal Opioid Overdoses in Marion County, Indiana
Journal of Urban Health
Environmental
Public Health
Health
Urban Studies
Occupational Health
Collaborative Effort Launches to Reduce Opioid Abuse and Misuse
Pharmacy Today
Can We Prevent Drug Related Deaths by Training Opioid Users to Recognise and Manage Overdoses?
Harm Reduction Journal
Mental Health
Environmental
Public Health
Psychiatry
Medicine
Occupational Health
Is Residential Treatment Effective for Opioid Use Disorders? A Longitudinal Comparison of Treatment Outcomes Among Opioid Dependent, Opioid Misusing, and Non-Opioid Using Emerging Adults With Substance Use Disorder
Drug and Alcohol Dependence
Psychiatry
Toxicology
Mental Health
Pharmacology
Pmh49 - Launching Long Acting Products to Treat Opioid Use Disorder: Are Payers Willing to Pay Premium Price?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Sustained Opioid Antagonism Modulates Striatal Sensitivity to Baby Schema in Opioid Use Disorder
Journal of Substance Abuse Treatment
Medicine
Clinical Psychology
Psychiatry
Psychiatric Mental Health
Mental Health
Opioid Users' Willingness to Receive Prolonged-Release Buprenorphine Depot Injections for Opioid Use Disorder
Journal of Substance Abuse Treatment
Medicine
Clinical Psychology
Psychiatry
Psychiatric Mental Health
Mental Health
Pmh74 - Quality of Life According to Temporal Illicit Opioid Use and Responder Rate in Adults Receiving Buprenorphine Depot Injections (Cam2038) to Treat Opioid Use Disorder in a 48-Week Open Label Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Opioid and Polydrug Use Among Patients in Opioid Maintenance Treatment
Substance Abuse and Rehabilitation
